Browsing Technical documents and research evidence on COVID-19 by Title
Now showing items 68-87 of 1749
-
Asian Genotype Zika Virus Detected in Traveler Returning to Mexico from Colombia, October 2015
(2016-06)Zika virus is an emerging arbovirus spread by Aedes aegypti mosquitoes and belongs to the genus Flavivirus of the Spondweni serocomplex (1,2). Most often, signs and symptoms of infection are maculopapular rash, fever, ... -
Assertive community treatment for adults with severe mental illness
(2020-05-13)What is this? The COVID-19 pandemic is placing a strain on healthcare services and resources. Existing research on Assertive Community Treatment (ACT) as a way to deliver mental health services may provide useful information ... -
Assessing the impact of non-pharmaceutical interventions on SARS-CoV-2 transmission in Switzerland
(2020-05-08)Following the rapid dissemination of COVID-19 cases in Switzerland, large-scale non- pharmaceutical interventions (NPIs) were implemented by the cantons and the federal government between February 28 and March 20. Estimates ... -
Assessing the potential risk of Zika virus epidemics in temperate areas with established Aedes albopictus populations
(2016-06)Based on 2015 abundance of Aedes albopictus in nine northern Italian municipalities with temperate continental/oceanic climate, we estimated the basic reproductive number R0 for Zika virus (ZIKV) to be systematically below ... -
Assessing Zika virus transmission dynamics and mitigation strategies. A multidisciplinary approach.
(2021)The project took place in three Latin American countries that have different epidemiological and ecological settings of Zika virus transmission: Colombia, Argentina and Ecuador; with the objective of characterizing the ... -
Assessment of Evidence for COVID-19-Related Treatments: Updated 4/17/2020
(2020-04-17)The information contained in this evidence table is emerging and rapidly evolving because of ongoing research and is subject to the professional judgment and interpretation of the practitioner due to the uniqueness of each ... -
Assessment of Hydroxychloroquine and Chloroquine Safety Profiles: A Systematic Review and Meta-Analysis
(2020-05-08)Background: Recently, chloroquine (CQ) and its derivative hydroxychloroquine (HCQ) have emerged as potential antiviral and immunomodulatory options for the treatment of 2019 coronavirus disease (COVID-19). To examine the ... -
Assessment of the efficacy and safety of Ribavirin in treatment of coronavirus-related pneumonia (SARS, MERS and COVID-19): A protocol for systematic review and meta-analysis
(2020-09-18)Background: The new coronavirus-related pneumonia is causing a global pandemic without specific antiviral drug. Ribavirin has activity against extensive RNA and DNA viruses. We plan to systematically review the use of ... -
Assessment tool for laboratories implementing COVID-19 virus testing. Interim guidance, 8 April 2020
(2020-04-08)Background: This tool has been designed to assess the capacity of laboratories that have implemented or intend to implement testing for SARS-CoV-2, the virus that causes novel coronavirus disease 2019 (COVID-19). The tool ... -
Associated ultrasonographic findings in fetuses with microcephaly because of suspected Zika virus (ZIKV) infection during pregnancy
(2016)OBJECTIVE: To describe fetal ultrasonographic findings and outcomes in a series of cases of fetal microcephaly associated with Zika virus infection. METHODS: Retrospective case series of microcephaly with definite ... -
The association between COVID‐19 and asthma: A systematic review and meta‐analysis
(2020-09-15)To the Editor, Recently, the associations between COVID‐19 and its comorbidities including hypertension, diabetes, obesity, cardiovascular disease, chronic obstructive pulmonary disease, chronic kidney disease, immunosuppression ... -
Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study
(2020-04-16)Background: Thrombocytopenia has been implicated in patients infected with severe acute respiratory syndrome coronavirus 2, while the association of platelet count and changes with subsequent mortality remains unclear. ... -
The association between severe or dead COVID-19 and autoimmune diseases: A systematic review and meta-analysis
(2020)COVID-19 is an acute inflammatory infectious disease. It is now generally accepted that the occurrence of autoimmune diseases is related to autoinflammatory8. Over the course of the COVID-19 pandemic, Zachary SW and ... -
Association between Zika virus and microcephaly in French Polynesia, 2013-15: A retrospective study
(2016-06)The emergence of Zika virus in the Americas has coincided with increased reports of babies born with microcephaly. On Feb 1, 2016, WHO declared the suspected link between Zika virus and microcephaly to be a Public Health ... -
Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study
(2016-06)BACKGROUND: The microcephaly epidemic, which started in Brazil in 2015, was declared a Public Health Emergency of International Concern by WHO in 2016. We report the preliminary results of a case-control study investigating ... -
Association of active oncologic treatment and risk of death in cancer patients with COVID-19: a systematic review and meta-analysis of patient data
(2020-11-02)Background: Cancer patients suffer from worse coronavirus disease-2019 (COVID-19) outcomes. Whether active oncologic treatment is an additional risk factor in this population remains unclear. Therefore, here we have conducted ... -
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
(2020-05-01)Type 2 diabetes (T2D) is a major comorbidity of COVID-19. However, the impact of blood glucose (BG) control on the degree of required medical interventions and on mortality in patients with COVID-19 and T2D remains uncertain. ... -
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
(2020-03-25)Importance Coronavirus disease 2019 (COVID-19) has resulted in considerable morbidity and mortality worldwide since December 2019. However, information on cardiac injury in patients affected by COVID-19 is limited. Objective ... -
Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis
(2020-08-26)Background: Estimating the risk of pre-existing comorbidities on coronavirus disease 2019 (COVID-19) mortality may promote the importance of targeting populations at risk to improve survival. This systematic review and ... -
Association of chemosensory dysfunction and Covid‐19 in patients presenting with influenza‐like symptoms
(2020-04-12)[Abstract]. Background: Rapid spread of the SARS‐CoV‐2 virus and concern for viral transmission by ambulatory patients with minimal to no symptoms underline the importance of identifying early or subclinical symptoms of ...